These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 8102244)
1. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines? Campling BG; Baer K; Baker HM; Lam YM; Cole SP Br J Cancer; 1993 Aug; 68(2):327-35. PubMed ID: 8102244 [TBL] [Abstract][Full Text] [Related]
2. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Cole SP; Downes HF; Mirski SE; Clements DJ Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221 [TBL] [Abstract][Full Text] [Related]
3. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines. Rhodes T; Twentyman PR Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774 [TBL] [Abstract][Full Text] [Related]
4. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107 [TBL] [Abstract][Full Text] [Related]
5. Glutathione and related enzyme activity in human lung cancer cell lines. Carmichael J; Mitchell JB; Friedman N; Gazdar AF; Russo A Br J Cancer; 1988 Oct; 58(4):437-40. PubMed ID: 2905163 [TBL] [Abstract][Full Text] [Related]
6. Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. Sharma R; Singhal SS; Srivastava SK; Bajpai KK; Frenkel EP; Awasthi S Cancer Lett; 1993 Dec; 75(2):111-9. PubMed ID: 8293421 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Jain N; Lam YM; Pym J; Campling BG Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677 [TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase isoenzymes in human lung tumors. Singh SV; Haque AK; Ahmad H; Medh RD; Awasthi YC Carcinogenesis; 1988 Sep; 9(9):1681-5. PubMed ID: 3409473 [TBL] [Abstract][Full Text] [Related]
9. Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines. Shellard SA; Fichtinger-Schepman AM; Lazo JS; Hill BT Anticancer Drugs; 1993 Aug; 4(4):491-500. PubMed ID: 8400352 [TBL] [Abstract][Full Text] [Related]
10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH; Gupta V; Singh SV Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448 [TBL] [Abstract][Full Text] [Related]
11. Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer. Oberli-Schrämmli AE; Joncourt F; Stadler M; Altermatt HJ; Buser K; Ris HB; Schmid U; Cerny T Int J Cancer; 1994 Dec; 59(5):629-36. PubMed ID: 7960235 [TBL] [Abstract][Full Text] [Related]
12. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype. Schisselbauer JC; Crescimanno M; D'Alessandro N; Clapper M; Toulmond S; Tapiero H; Tew KD Cancer Commun; 1989; 1(2):133-9. PubMed ID: 2639724 [TBL] [Abstract][Full Text] [Related]
13. Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data. Bracht K; Liebeke M; Ritter CA; Grünert R; Bednarski PJ Anticancer Drugs; 2007 Apr; 18(4):389-404. PubMed ID: 17351391 [TBL] [Abstract][Full Text] [Related]
14. Levels of glutathione S transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Nakagawa K; Yokota J; Wada M; Sasaki Y; Fujiwara Y; Sakai M; Muramatsu M; Terasaki T; Tsunokawa Y; Terada M Jpn J Cancer Res; 1988 Mar; 79(3):301-4. PubMed ID: 2836347 [TBL] [Abstract][Full Text] [Related]
15. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Lewis AD; Hayes JD; Wolf CR Carcinogenesis; 1988 Jul; 9(7):1283-7. PubMed ID: 2898306 [TBL] [Abstract][Full Text] [Related]
16. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. Ahn H; Lee E; Kim K; Lee C J Urol; 1994 Jan; 151(1):263-7. PubMed ID: 8254825 [TBL] [Abstract][Full Text] [Related]
17. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279 [TBL] [Abstract][Full Text] [Related]
18. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Lau DH; Lewis AD; Ehsan MN; Sikic BI Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140 [TBL] [Abstract][Full Text] [Related]
19. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines. Hosking LK; Whelan RD; Shellard SA; Bedford P; Hill BT Biochem Pharmacol; 1990 Oct; 40(8):1833-42. PubMed ID: 2242017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]